Cargando…

Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis

BACKGROUND: Grass pollen-induced allergic rhinoconjunctivitis constitutes a large burden for society. Up to 20% of European and United States (US) populations suffer from respiratory allergies, including grass pollen-induced allergic rhinoconjunctivitis. The majority of patients are treated with sym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rønborg, Steen M, Svendsen, Ulrik G, Micheelsen, Jesper S, Ytte, Lars, Andreasen, Jakob N, Ehlers, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500916/ https://www.ncbi.nlm.nih.gov/pubmed/23166443 http://dx.doi.org/10.2147/CEOR.S34832

Ejemplares similares

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
por: Hebert, Jacques, et al.
Publicado: (2011)

Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis
por: Pfaar, O., et al.
Publicado: (2017)

488 The Effect of Specific Immunotherapy on the Clinical Response in Patients with Grass-pollen Induced Rhinoconjunctivitis
por: Arsovski, Zoran, et al.
Publicado: (2012)

Evaluation of the frequency and severity of seasonal allergic rhinoconjunctivitis caused by grass pollen in children with hazelnut sensitization
por: Cavkaytar, O, et al.
Publicado: (2013)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
por: Demoly, Pascal, et al.
Publicado: (2015)

Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
por: Schäfer, Udo, et al.
Publicado: (2017)

Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy
por: Poole, Chris D, et al.
Publicado: (2014)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis
por: Didier, Alain, et al.
Publicado: (2012)

Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis
por: McDonell, Amanda L., et al.
Publicado: (2015)

Allergic rhinoconjunctivitis
por: Miraglia del Giudice, Michele, et al.
Publicado: (2020)

Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial
por: Hylander, Terese, et al.
Publicado: (2016)

Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
por: Verheggen, Bram G, et al.
Publicado: (2015)

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma
por: Traina, Giovanni Maria, et al.
Publicado: (2021)

Comparison of tear proteome in allergic rhinoconjunctivitis patients and controls with respect to pollen season
por: Tomazic, P. V., et al.
Publicado: (2018)

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2017)

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
por: Nurmatov, Ulugbek, et al.
Publicado: (2017)

Efficiacy of injection specific immunotherapy for grass pollen seasonal allergic rhinitis
por: Wasilewska, Eliza, et al.
Publicado: (2015)

Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
por: Penagos, Martin, et al.
Publicado: (2018)

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
por: Proctor, Thomas, et al.
Publicado: (2020)

Allergic Rhinoconjunctivitis: the Role of Histamine
por: Andersson, M., et al.
Publicado: (1994)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
por: Kim, Harold, et al.
Publicado: (2014)

Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen
por: Ahlbeck, Lars, et al.
Publicado: (2022)

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: Impact of sensitization to subtropical grass pollen
por: van Nunen, Sheryl A., et al.
Publicado: (2022)

A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
por: Alesina, Roberta, et al.
Publicado: (2012)

Relationship between allergic rhinitis and allergic conjunctivitis (allergic rhinoconjunctivitis) - review
por: Iordache, Andreea, et al.
Publicado: (2022)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy
por: Langenbruch, Anna, et al.
Publicado: (2022)

ITULAZAX(®) versus Alutard SQ(®) in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost‐minimization modeling analysis from the Danish societal perspective
por: Rønborg, Steen M., et al.
Publicado: (2022)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2023)

Evaluation of birch pollen sensitization profile in allergic rhinoconjunctivitis patients from Bucharest region using component-resolved diagnosis
por: Popescu, Florian-Dan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3q5eoe46c3dovovvjmfpl0bpco